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0.362 Abbreviations: MM = Multiple Melanomas; DLBCL = Diffuse large B-cell lymphoma; UGI cancer = upper gastrointestinal tract (UGI) cancers (including esophagus cancer, gastric cancer, and small intestine cancer); HCC = hepatocellular carcinoma; NSCLC = non-small cell lung cancer; UTUC = upper tract urothelial carcinoma; OS = overall survival; HR = hazard ratio; CI = confidence interval; P D = P for subgroup difference; P H = P for heterogeneity.
*: Cheng et al 2015 separately evaluated the survival outcome in two cohorts, which were derivation cohort and validation cohort.
#: Cut-off value of RDW was based on previous study. ‡: HRs were extracted from multivariate cox proportional hazards models, univariate cox proportional hazards models or survival curve analysis. Adequate assessment included 1) representativeness of population: "source population clearly defined" and "study population described" or "study population represents source population or population of interest"; 2) completeness of follow-up: "completeness of follow-up adequate"; 3) non exposed cohort: Drawn from the same community as the exposed cohort; 4) sufficient measurement of outcomes: "outcome measured appropriately"; 5) appropriate confounding measurement and account: "confounders defined and measured" and "confounding accounted for"; and 6) outcome of interest was not present at start of study *References as described in manuscript Supplementary Table. 4 Sensitivity analysis using a "one-study removed" model for OS subset. 
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